Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Circulating microRNAs Signature for Predicting Response to GLP1-RA Therapy in Type 2 Diabetic Patients: A Pilot Study

31 Aug 2021

Abstract excerpt

Type 2 diabetes (T2D) represents one of the major health issues of this century. Despite the availability of an increasing number of anti-hyperglycemic drugs, a significant proportion of patients are inadequately controlled, thus highlighting the need for novel biomarkers to guide treatment selection. MicroRNAs (miRNAs) are small non-coding RNAs, proposed as useful diagnostic/prognostic markers. The aim of our...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Diabetes Treatment and Management
Share to Pancreatic function and diabetes
Share to Regulation of Appetite and Obesity

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 34502360
DOI: 10.3390/ijms22179454

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Circulating microRNAs Signature for Predicting Response to GLP1-RA Therapy in Type 2 Diabetic Patients: A Pilot StudyPMID 34502360Read ↗

miRNAs: early prognostic biomarkers for Type 2 diabetes mellitus?Semantic proximity Read ↗

MicroRNA expression profile in plasma from type 1 diabetic patients: Case-control study and bioinformatic analysisSemantic proximity Read ↗

Circulating miRNA expression in long-standing type 1 diabetes mellitusSemantic proximity Read ↗

Therapeutic Potential of miRNAs for Type 2 Diabetes Mellitus: An OverviewSemantic proximity Read ↗

Plasma Exosome MicroRNA Profiling Unravels a New Potential Modulator of Adiponectin Pathway in Diabetes: Effect of Glycemic ControlSemantic proximity Read ↗

Circulating miRNA Profiles Associated With Hyperglycemia in Patients With Type 1 DiabetesSemantic proximity Read ↗

Plasma miR-126 is a potential biomarker for early prediction of type 2 diabetes mellitus in susceptible individuals.Semantic proximity Read ↗

Role of microRNAs in the treatment of type 2 diabetes mellitus with Roux-en-Y gastric bypassSemantic proximity Read ↗

Downregulation of miR-24-3p and miR-198 in Newly Diagnosed type 2 Diabetes MellitusSemantic proximity Read ↗

Identifying common and specific microRNAs expressed in peripheral blood mononuclear cell of type 1, type 2, and gestational diabetes mellitus patientsSemantic proximity Read ↗

MicroRNA 144 Impairs Insulin Signaling by Inhibiting the Expression of Insulin Receptor Substrate 1 in Type 2 Diabetes MellitusSemantic proximity Read ↗

Increased expression of microRNAs, miR-20a and miR-326 in PBMCs of patients with type 1 diabetesSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.